Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BELLEVUE, Wash., Feb. 1, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed a Letter of Intent (LOI) with Aeras Global TB Vaccine Foundation to enter into an R&D...
-
BELLEVUE, Wash., Jan. 12, 2010 (GLOBE NEWSWIRE) -- TapImmune, Inc. (OTCBB:TPIV) announced that it has retained Wolfe Axelrod Weinberger Associates LLC as its investor relations counsel to communicate...
-
BELLEVUE, Wash., Jan. 11, 2010 (GLOBE NEWSWIRE) -- TapImmune, Inc. (OTCBB:TPIV) announced today President Denis Corin will be presenting at the OneMedPlace's Forum 2010, Emerging Company Finance...
-
BELLEVUE, Wash., Nov. 25, 2009 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious...
-
BELLEVUE, Wash., Nov. 5, 2009 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases,...
-
BELLEVUE, Wash., Nov. 4, 2009 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious...
-
BELLEVUE, Wash., Oct. 7, 2009 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases,...
-
BELLEVUE, Wash., Oct. 1, 2009 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases,...
-
VANCOUVER, British Columbia, Aug. 16, 2007 (PRIME NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIM) (Germany:GX1A), a biotechnology company specializing in the development of immunotherapeutics for cancer and...
-
VANCOUVER, British Columbia, Aug. 1, 2007 (PRIME NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for...